S&P 500
(2.11%) 5 087.03 points
Dow J
(1.18%) 39 069 points
Nasdaq
(2.96%) 16 042 points
Oil
(0.69%) $78.45
Gas
(-2.54%) $1.728
Gold
(0.01%) $2 034.60
Silver
(-0.40%) $22.78
Platinum
(2.01%) 907.45
USD/EUR
(0.00%) 0.924
USD/NOK
(0.45%) 10.51
USD/GBP
(-0.17%) 0.790
USD/RUB
(1.16%) 93.05

Realtime updates for Pacific Edge Limited [PEB.NZ]

Exchange: EURONEXT Sector: Healthcare Industry: Diagnostics & Research
Last Updated22 Feb 2024 @ 16:09

2.17% NZD 0.0940

Live Chart Being Loaded With Signals

Commentary (22 Feb 2024 @ 16:09):

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore...

Stats
Today's Volume 12 474.00
Average Volume 1.70M
Market Cap 76.17M
EPS NZD0 ( 2023-11-21 )
Last Dividend NZD0 ( N/A )
Next Dividend NZD0 ( N/A )
P/E -2.35
ATR14 NZD0.0010 (1.06%)

Pacific Edge Limited Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators